1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Patología Molecular del Cáncer

Patología Molecular del Cáncer

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Moreno Moreno, Esther, Ferrer-Gomez, Ana, Arias HP, Garcia Garcia, Irene, Garcia-Cosio, Monica.

    Fibrin-associated diffuse large B-cell lymphoma with plasmacytic differentiation: case report and literature review

    DIAGNOSTIC PATHOLOGY . 15(1): 117-117. Nº de citas: 5

    [doi:10.1186/s13000-020-01034-7]

  • Grande, Enrique, Teule, Alex, Alonso-Gordoa, Teresa, Jimenez-Fonseca, Paula, Benavent, Marta, Capdevila, Jaume, Custodio, Ana, Vera, Ruth, Munarriz, Javier, La Casta, Adelaida, Díez JJ, Gajate, Pablo, Molina-Cerrillo, Javier, Matos, Ignacio, Cristóbal EM, Ruffinelli, Jose C., Palacios, Jose, Garcia-Carbonero, Rocio.

    The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407)

    ONCOLOGIST . 25(9): 745-745. Nº de citas: 19

    [doi:10.1634/theoncologist.2020-0033]

  • Romero, Ignacio, Leskela, Susanna, Mies, Belen Perez, Velasco, Andres Poveda, Palacios, Jose.

    Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications.

    EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.] . 15: 1-15. Nº de citas: 10

    [doi:10.1016/j.ejcsup.2020.02.001]

  • Moreno, Esther, Rosa-Rosa, Juan M., Caniego-Casas, Tamara, Ruz-Caracuel, Ignacio, Perna, Cristian, Guillen, Carmen, Palacios, Jose.

    Next generation sequencing to decipher concurrent loss of PMS2 and MSH6 in colorectal cancer

    DIAGNOSTIC PATHOLOGY . 15(1): 84-84. Nº de citas: 3

    [doi:10.1186/s13000-020-01001-2]

  • COVID-19 Autopsy. Electronic address: anapat.hrc@salud.madrid.org, PALACIOS, J..

    The first COVID-19 autopsy in Spain performed during the early stages of the pandemic.

    REVISTA ESPANOLA DE PATOLOGIA . 53(3): 182-187. Nº de citas: 21

    [doi:10.1016/j.patol.2020.05.004]

  • Gonzalez-Martinez, Silvia, Perez-Mies, Belen, Carretero-Barrio, Irene, Palacios-Berraquero ML, Perez-Garcia, Jose, Cortes, Javier, Palacios, Jose.

    Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma

    Cancers . 12(7): . Nº de citas: 23

    [doi:10.3390/cancers12071832]

  • Leskela, Susanna, Romero, Ignacio, Rosa-Rosa, Juan M., Caniego-Casas, Tamara, Cristobal, Eva, Perez-Mies, Belen, Gutierrez-Pecharroman, Ana, Santon, Almudena, Ojeda, Belen, Lopez-Reig, Raquel, Palacios-Berraquero, Maria L., Andrada, Encarna, Montes, Santiago, Pastor, Francisco, Gomez, Maria C., Lopez-Guerrero, Jose A., Poveda, Andres, Palacios, Jose.

    Molecular Heterogeneity of Endometrioid Ovarian Carcinoma An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY . 44(7): 982-990. Nº de citas: 23

    [doi:10.1097/PAS.0000000000001478]

  • Molina-Cerrillo, Javier, San Roman, Maria, Pozas, Javier, Alonso-Gordoa, Teresa, Pozas, Miguel, Conde, Elisa, Rosas, Marta, Grande, Enrique, Garcia-Bermejo, Maria Laura, Carrato, Alfredo.

    BRAF Mutated Colorectal Cancer: New Treatment Approaches

    Cancers . 12(6): . Nº de citas: 35

    [doi:10.3390/cancers12061571]

  • López-García MÁ, Carretero-Barrio, Irene, Perez-Mies, Belen, Chiva, Miguel, Castilla, Carolina, Vieites, Begona, Palacios, Jose.

    Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers

    Cancers . 12(6): . Nº de citas: 3

    [doi:10.3390/cancers12061578]

  • Leskela, Susanna, Romero, Ignacio, Cristobal, Eva, Perez-Mies, Belen, Rosa-Rosa, Juan M., Gutierrez-Pecharroman, Ana, Caniego-Casas, Tamara, Santon, Almudena, Ojeda, Belen, Lopez-Reig, Raquel, Palacios-Berraquero, Maria L., Garcia, Angel, Ibarra, Javier, Hakim, Sofia, Guarch, Rosa, Lopez-Guerrero, Jose A., Poveda, Andres, Palacios, Jose.

    Mismatch Repair Deficiency in Ovarian Carcinoma Frequency, Causes, and Consequences

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY . 44(5): 649-656. Nº de citas: 38

    [doi:10.1097/PAS.0000000000001432]

  • Palacios J, de la Hoya M, Bellosillo B, de Juan I, Matías-Guiu X, Lázaro C, Palanca S, Osorio A, Rojo F, Rosa-Rosa JM, Cigudosa JC.

    Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH).

    VIRCHOWS ARCHIV . 476(2): 195-207. Nº de citas: 12

    [doi:10.1007/s00428-019-02709-3]

  • Leskela, Susanna, Romero, Ignacio, Cristobal, Eva, Perez-Mies, Belen, Rosa-Rosa, Juan M., Gutierrez-Pecharroman, Ana, Santon, Almudena, Gonzalez, Belen O., Lopez-Reig, Raquel, Hardisson, David, Vera-Sempere, Francisco, Illueca, Carmen, Vieites, Begona, Lopez-Guerrero, Jose A., Palacios, Jose, Poveda, Andres.

    The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY . 44(2): 149-161. Nº de citas: 16

    [doi:10.1097/PAS.0000000000001365]

  • Garrote-Corral, Sandra, Sifuentes-Giraldo, Walter Alberto, Reguero-Callejas, María Eugenia, Vázquez-Díaz, Mónica.

    Osteomalacia oncogénica secundaria a tumor mesenquimal fosfatúrico del pie

    Revista Colombiana de Reumatología . 27(3): 210-214.

    [doi:10.1016/j.rcreu.2019.09.001]

  • Martinez-Ciarpaglini, Carolina, Exposito-Afonso, Idaira, Iglesias, Mar, Perez-Mies, Belen.

    [Pathology training in Spain: What is the status quo and how should we improve?]

    REVISTA ESPANOLA DE PATOLOGIA . 53(1): 3-9. Nº de citas: 1

    [doi:10.1016/j.patol.2019.06.003]

  • González-García A, de la Peña JLP, García-Cosio M, Sarhane Y, Díaz CS, Díaz IB, Rodríguez ML, Ángeles Moreno M, Villarubia J, Manzano L.

    Clinical and pathological characteristics of Castleman disease: an observational study in a Spanish tertiary hospital.

    LEUKEMIA & LYMPHOMA . 60(14): 1-7. Nº de citas: 6

    [doi:10.1080/10428194.2019.1639168]

  • Palacios J, Matías-Guiu X, Rodríguez-Peralto JL, de Álava E, López JI.

    Retos e implicaciones clínicas de la heterogeneidad intratumoral.

    REVISTA ESPANOLA DE PATOLOGIA . 52(4): 234-241.

    [doi:10.1016/j.patol.2019.04.004]

  • Molina-Crespo A, Cadete A, Sarrio D, Gamez-Chiachio M, Martinez L, Chao K, Olivera A, Gonella A, Diaz E, Palacios J, Dhal PK, Besev M, Rodriguez-Serrano M, García-Bermejo ML, Triviño JC, Cano A, Garcia-Fuentes M, Herzberg O, Torres D, Alonso MJ, Moreno-Bueno G.

    Intracellular delivery of an antibody targeting Gasdermin-B reduces HER2 breast cancer aggressiveness.

    CLINICAL CANCER RESEARCH . 25(15): 4846-4858. Nº de citas: 34

    [doi:10.1158/1078-0432.CCR-18-2381]

  • Leskela S, Pérez-Mies B, Rosa-Rosa JM, Cristobal E, Biscuola M, Palacios-Berraquero ML, Ong S, Matias-Guiu Guia X, Palacios J.

    Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma.

    Cancers . 11(7): . Nº de citas: 32

    [doi:10.3390/cancers11070964]